Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cross Country Healthcare Inc Issues Q4 2013 Guidance; Revenue Guidance Below Analysts' Estimates


Wednesday, 6 Nov 2013 05:00pm EST 

Cross Country Healthcare Inc announced that for the fourth quarter of 2013, it expects revenue to be in the $107 million to $110 million range. Earnings per diluted share (EPS) from continuing operations to be in the range of $0.00 to $0.02. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $112 million and EPS of $0.01 for the third quarter of 2013. 

Company Quote

10.96
 --
5 Mar 2015